Search results
3 sty 2024 · Dr. Leon Ferre and other researchers at Mayo Clinic are working to understand how triple-negative breast cancer grows and spreads, how the immune system may recognize and fight it, and to develop new treatments for the disease.
5 gru 2023 · Their BRCA1 variants came to light through a Mayo Clinic Center for Individualized Medicine DNA sequencing study. The study highlights the importance of genetic screening and the potential for hereditary health concerns.
21 paź 2023 · The BRCA gene test looks for changes in the BRCA1 and BRCA2 genes. Other genes also can increase the risk of breast and ovarian cancer. Some genetic tests look for these other genes in addition to the BRCA genes. A genetic test that looks at many different genes is called a multigene panel test.
1 cze 2018 · Factors associated with an increased risk of breast cancer include older age, female sex, positive family history, deleterious gene sequence variations (BRCA1, BRCA2, CHEK2, PALB2, and others; for expansion of gene symbols, use search tool at www.genenames.org), 5 increased mammographic breast density, reproductive factors (eg, nulliparity ...
Many women are interested in cancer risk–reduction surgery before the recommended ages for RRSO. Bilateral tubal ligation offers an interesting intermediate option for BRCA1 mutation carriers.
10 paź 2024 · DEAR MAYO CLINIC: I understand surgery ... Lumpectomy is a treatment option for early-stage breast cancer. Compared with a mastectomy, it's less invasive and tends to have a quicker recovery. ... Individuals with a genetic predisposition for breast cancer, such as the BRCA1 or BRCA2 gene mutation, may opt for a mastectomy as a preventive ...
Women with a germline BRCA1 or BRCA2 mutation or a hereditary predisposition for breast and ovarian cancer have substantial risk of breast or ovarian cancer relative to the general US population.
